T cell-regulated neutrophilic inflammation in autoinflammatory diseases

Journal of Immunology

Volumn 175, Issue 11, 2005, Pages 7678-7686

  Keller, Monika ^a   Spanou, Zoi ^a   Schaerli, Patrick ^b   Britschgi, Markus ^a   Yawalkar, Nikhil ^c   Seitz, Michael ^a   Villiger, Peter M ^a   Pichler, Werner J ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR8; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; BEHCET DISEASE; CLINICAL ARTICLE; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PUSTULAR PSORIASIS; PUSTULOSIS; RASH; SKIN BIOPSY; SKIN INFLAMMATION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 28244431899     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.11.7678     Document Type: Article

References (46)

1. Baker, H., and T. Ryan. 1968. Generalized pustular psoriasis: a clinical and epidemiological study of 104 cases. Br. J. Dermatol. 80: 771-793.
2. Beylot, C., P. Bioulac, and M. Doutre, S. 1980. Acute generalized exanthematic pustuloses (four cases). Ann. Dermatol. Venerol. 107: 37-48.
3. Roujeau. J., P. Bioulac-Sage, and C. Bourseau. 1991. Acute generalized exanthematous pustulosis: analysis of 63 cases. Arch. Dermatol. 127: 1333-1338.
4. Roujeau, J. C. 2000. Neutrophilic drug eruptions, Clin. Dermatol. 18: 331-337.
5. Sidoroff, A., S. Halevy, J. N. Bavinck, L. Vaillant, and J. C. Roujeau. 2001. Acute generalized exanthematous pustulosis (AGEPJ: a clinical reaction pattern. J. Cutan. Pathol. 28: 113-119.
6. Schaerli, P., M. Britschgi, M. Keller, U. C. Steiner, L. S. Steinmann, B. Moser, and W. J. Fichier. 2004. Characterization of human T cells that regulate neutrophilic skin inflammation. J. Immunol. 173: 2151-2158.
7. Jan, V., L. Machet, N. Gironet, L. Martin, M. C. Machet, G. Lorette, and L. Vaillant. 1998. Acute generalized exanthematous pustulosis induced by dilitiazem: value of patch testing. Dermatology 197: 274-275.
8. Britschgi, M., U. C. Steiner, S. Schmid, J. P. Depta, G. Senti, A. Bircher, C. Burkhart, N. Yawalkar, and W. J. Pichler. 2001. T cell involvement in drug-induced acute generalized exanthematous pustulosis. J. Clin: Invest. 107: 1433-1441.
9. Britschgi, M., and W. J. Pichler. 2002. Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr. Opin. Allergy Clin. Immunol. 2: 325-331.
10. Schmid, S., P. C. Kuechler, M. Britschgi, U. C. Steiner, N. Yawalkar, A. Limat, K. Baltensperger, L. Braathen, and W. J. Pichler. 2002. Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation. Am. J. Pathol. 161: 2079-2086.
11. Hirohata, S., and H. Kikuchi. 2003. Behcet's disease. Arthritis Res. Ther. 5: 139-146.
12. Terui, T., M. Ozawa, and H. Tagami. 2000. Role of neutrophils in induction of acute inflammation in T cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop. Exp. Dermatol. 9: 1-10.
13. Kobayashi, M., M. Ito. A. Nakagawa, M. Matsushita, N. Nishikimi. T. Sakurai, and Y. Nimura. 2000. Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behcet disease. Histopathology 36: 362-371.
14. Gudjonsson, J. E., A. Johnston, H. Sigmundsdottir, and H. Valdimarsson. 2004. Immunopathogenic mechanisms in psoriasis, Clin. Exp. Immunol 135: 1-8.
15. Bos, J. D., and M. A. De Rie. 1999. The pathogenesis of psoriasis: immunological facts and speculations. Immunol. Today 20: 40-46.
16. Kaburaki, T., Y. Fujino, H. Kawashima, G. Merino, J. Numaga, J. Chen, and K. Matsushima. 2003. Plasma and whole-blood chemokine levels in patients with Behcet's disease. Graefes Arch. Clin. Exp. Ophthalmol. 241: 353-358.
17. Duan, H., T. Koga, F. Kohda, H. Hara, K. Urabe, and M. Furue. 2001. Interleukin-8-positive neutrophils in psoriasis. J. Dermatol. Sci. 26: 119-124.
18. Jiang, W. Y., A. D. Chattedee, S. P. Raychaudhuri, S. K. Raychaudhuri, and E. M. Farber. 2001. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Int. J. Dermatol. 40: 99-703.
19. Yawalkar, N., F. Egli, Y. Hari, H. Nievergelt, L. R. Braathen, and W. J. Fichier. 2000. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin. Exp. Allergy 30: 847-S55.
20. Yawalkar, N., M. Shrikhande, Y. Hari, H. Nievergelt, L. R. Braathen, and W. J. Pichler. 2000. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J. Allergy Clin. Immunol. 106: 1171-1176.
21. Zanni, M. P., D. Mauri-Hellweg, C. Brander, T. Wendland, B. Schnyder, E. Frei, S. von Greyerz, A. Bircher, and W. J. Pichler. 1997. Characterization of lidocaine-specific T cells. J. Immunol. 158: 1139-1148.
22. Schaerli, P., L. Ebert, K. Willimann, A. Blaser, R. S. Roos, P. Loetscher, and B. Moser. 2004. A skin-selective homing mechanism for human immune surveillance T cells. J. Exp. Med. 199: 1265-1275.
23. Ong, P. Y., and D. Y. Leung. 2002. The chemokine receptor CCR6 identifies interferon γ expressing T cells and is decreased in atopic dermatitis as compared with psoriasis. J. Invest. Dermatot. 119: 1463-1464.
24. Homey, B., M. C. Dieu-Nosjean, A. Wiesenborn, C. Massacrier, J. J. Pin, E. Oldham, D. Catron, M. E. Buchanan, A. Muller, R. DeWaal Malefyt, et al. 2000. Up-regulation of macrophage inflammatory protein-3α/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164: 6621-6632.
25. Schmuth, M., S. Neyer, C. Rainer, A. Grassegger, P. Fritsch, N. Romani, and C. Heufler. 2002. Expression of the C-C chemokine MIP-3α/CCL20 in human epidermis with impaired permeability barrier function. Exp. Dermatol. 11: 135-142.
26. Nakayama, T., R. Fujisawa, H. Yamada, T. Horikawa, H. Kawasaki, K. Hieshima, D. Izawa, S. Fujiie, T. Tezuka, and O. Yoshie. 2001. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LAR)/macrophage inflammatory protein (MIP)-3α/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int. Immunol. 13: 95-103.
27. Schutyser, E., S. Struyf, and J. Van Damme. 2003. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14: 409-426.
28. Albanesi, C., C. Scarponi, S. Sebastiani, A. Cavani, M. Federici, S. Sozzani, and G. Girolomoni. 2001. A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases. J. Leukocyte Biol. 70: 617-623.
29. Schlaak, J. F., M. Buslau, W. Jochum, E. Hermann, M. Girndt, H. Gallati, K. H. Meyer zum Buschenfelde, and B. Fleischer. 1994. T cells involved in psoriasis vulgaris belong to the Th1 subset. J. Invest. Dermatol. 102: 145-149.
30. Szegedi, A., M. Aleksza, A. Gonda, B. Irinyi, S. Sipka, J. Hunyadi, and P. Antal-Szalmas. 2003. Elevated rate of T helperl (T(h)l) lymphocytes and serum IFN-γ levels in psoriatic patients. Immunol. Lett. 86: 277-280.
31. Austin, L. M., M. Ozawa, T. Kikuchi, I. B. Walters, and J. G. Krueger. 1999. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon γ, interleukin-2, and tumor necrosis factor α, defining TCl (cytotoxic T lymphocyte) and Th1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J. Invest. Dermatol. 113: 752-759.
32. Ben Ahmed, M., H. Houman, M. Miled, K. Dellagi, and H. Louzir. 2004. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocuta-neous lesions of Behcet's disease. Arthritis Rheum. 50: 2291-2295.
33. Frassanito, M. A., R. Dammacco, P. Cafforio, and F. Dammacco. 1999. Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum. 42: 1967-1974.
34. Confino-Cohen, R., A. Goldberg, D. Aharoni, L. Naiman, A. Buchs, M. Weiss, J. Weissgarten, and M. J. Rapoport. 2004. Low stimulated IL-4 secretion in PBMC from patients with chronic idiopathic urticaria. Cytokine 27: 74-80.
35. Renz, H., K. Jujo, K. L. Bradley, J. Domenico, E. W. Gelfand, and D. Y. Leung. 1992. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon γ. J. Invest. Dermatol. 99: 403-408.
36. Hamid, Q., M. Boguniewicz, and D. Y. Leung. 1994. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest. 94: 870-876.
37. Robert, C., and T. S. Kupper. 1999. Inflammatory skin diseases. T cells, and immune surveillance. N. Engl. J. Med. 341: 1817-1828.
38. Manias, C., H. Direskeneli, D. Oz, S. Yavuz, and T. Akoglu. 2000. 1L-8 pro-ducing cells in patients with Behcet's disease. Clin. Exp. Rheumatol. 18: 249-251.
39. Bozkurt, N., H. Kazokoglu, S. Yavuz, T. Bavbek, and H. Direskeneli. 2003. Elevated serum chemokine levels in Behcet's disease with uveitis. Rheumatol. Int. 23: 268-269.
40. al-Dalaan, A., S. al-Sedairy, S. al-Balaa. M. al-Janadi, K. Elramahi, S. Bahabri, and S. Siddiqui. 1995. Enhanced interleukin 8 secretion in circulation of patients with Behcet's disease. J. Rheumatol 22: 904-907.
41. Fossati, G., I. Mazzucchelli, D. Gritti, G. Ricevuti, S. W. Edwards, D. A. Moulding, and M. L. Rossi. 1998. In vitro effects of GM-CSF on mature peripheral blood neutrophils. Int. J. Mol. Med. 1: 943-951.
42. Saba, S., G, Soong, S. Greenberg, and A. Prince. 2002. Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways. Am. J. Respir. Cell Mol. Biol. 27: 561-567.
43. Simon, H. U. 2003. Neutrophil apoptosis pathways and their modifications in inflammation, Immunol. Rev. 193: 101-110.
44. Mochizuki, M., E. Monta, S. Yamamoto, and S. Yamana. 1997, Characteristics of T cell lines established from skin lesions of Behcet's disease. J. Dermatol. Sci. 15: 9-13.
45. Giustizieri, M. L., F. Mascia, A. Frezzolini, O. De Pita, L. M. Chinni, A. Giannetti, G. Girolomoni. and S. Pastore. 2001. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J. Allergy Clin, Immunol. 107: 871-877.
46. Murphy, K. M., W. Ouyang, J. D. Farrar, J. Yang, S. Ranganath, H. Asnagli, M. Afkarian, and T. L. Murphy. 2000. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18: 451-494.